Specialized Research Khavinson Bioregulator

Vesilute

Also known as: Peptídeo imune

Molecular Identifiers

Molecular Formula

C9H14N2O7

PubChem CID

99716

Molecular Weight

262.22 Da

Overview

Immunological bioregulatory dipeptide developed by the Khavinson group. Modulates gene expression in immune cells and regulates leukocyte function. Used in short cycles for immune modulation and support of the body's defense.

Sequence (1 letter): ED

Extended notation: Glu-Asp

Half-life

~2-4 hours

Administration Route

Subcutaneous or intramuscular

Mechanism of Action

Immune modulation and regulation of immune response
Regulation of leukocyte function and activity
Normalization of cytokine and immune mediator production
Support for immunosurveillance and defense against pathogens
Bioregulatory effect on cellular and humoral immune system

Dosage Protocol

Data compiled from the literature. This does not constitute medical advice.

Parameter	Value
Dose	5-10 mg per day via subcutaneous injection
Frequency	Once daily
Timing	Morning or as per protocol
Duration	10-20 days, cycled 2-4 times per year

Reported Side Effects

Adverse effects described in the literature. Severity and frequency vary between individuals.

Injection site pain
Local redness (rare)

Product Properties

Purity	>95%
Appearance	White lyophilized powder
Solubility	Soluble in water and bacteriostatic water
Source	Solid-phase peptide synthesis (SPPS)
Storage	Lyophilized: -20°C for up to 2 years, 2-8°C for up to 6 months. Reconstituted: 2-8°C for up to 4 weeks. Protect from light and moisture. Avoid repeated freeze-thaw cycles.